2,3-DICHLOROBENZOIC ACID,
50-45-3,
Benzoic acid, 2,3-dichloro-,
2,3-Dichloro benzoic acid,
2,3-Dichorobenzoic acid,
UNII-CGP39QV5WF,
BRN 1946217,
Benzoic acid, dichloro-,
EINECS 200-039-5,
CGP39QV5WF,
DICHLOROBENZOIC ACID,
AI3-33364,
QAOJBHRZQQDFHA-UHFFFAOYSA-N,
MFCD00002413,
Lamotrigine Impurity E,
PubChem8198,
ACMC-209kmq,
2,3 dichlorobenzoic acid,
DSSTox_CID_4976,
2,3-dichloro-benzoic acid,
EC 200-039-5,
DSSTox_RID_77605,
DSSTox_GSID_24976,
SCHEMBL97298,
KSC273G4J,
AC1L1L38,
RARECHEM AL BO 0323,
CHEMBL1353833,
DTXSID5024976,
CTK1H3344,
TIMTEC-BB SBB003641,
2,3-Dichlorobenzoic acid, 97%,
ZINC157872,
AC1Q7279,
ACT04678,
KS-00000L3I,
Tox21_201189,
ANW-31008,
SBB003641,
STL195584,
AKOS000119479,
AM81265,
AS00737,
CM12640,
CS-W013224,
FR-2156,
LS-1305,
LS11460,
MCULE-9359043479,
RTC-062265,
CAS-50-45-3,
NCGC00091187-01,
NCGC00091187-02,
NCGC00258741-01,
AC-12726,
AJ-15119,
AK-48292,
AN-41557,
SC-04874,
ST088105,
SY023164,
AB0011183,
DB-019712,
ST2415648,
TC-062265,
TL8003347,
D3319,
FT-0609556,
MFCD00002413 (98%),
50D453,
K-9340,
I01-0388,
W-105960,
Z56899108,
2,3-Dichlorobenzoic acid, pharmaceutical impurity standard,
Lamotrigine impurity E, European Pharmacopoeia (EP) Reference Standard,
InChI=1/C7H4Cl2O2/c8-5-3-1-2-4(6(5)9)7(10)11/h1-3H,(H,10,11,
Lamotrigine Related Compound B, United States Pharmacopeia (USP) Reference Standard,
2,3-Dichlorobenzoic acid (Lamotrigine Related Compound B)(Lamotrigine Impurity E), Pharmaceutical Secondary Standard; Certified Reference Material,
2,3-dichlorbenzoesyre,
2,3-Dichlorobenzoicacid,
C7H4Cl2O2,
C7-H4-Cl2-O2,
CID5765,
2,4(Or 2,5)-dichlorobenzoic acid,
2,3-Dichlorobenzoic acid, 98% 10g,
CS-M-02269,
4-09-00-00998 (Beilstein Handbook Reference),
2,3-Dichlorobenzoic acid, 98% - 100G 100g,